Premarket Approval For COVID-19 Test Is US FDA's First For OTC Respiratory Diagnostic

FDA’s first premarket approval of OTC test for any respiratory illness went to first firm to receive an EUA for at-home molecular COVID-19 test, Cue Health, which had received $481m from agency to spur its diagnostics development.